Introduction to the 1st Molecules Medicinal Chemistry Symposium (MMCS), Barcelona, 8 September 2017
- Cell-based medicinal chemistry optimization of high-throughput screening hits towards orally active antimalarial and antituberculosis agents, by Kelly CHIBALE, Department of Chemistry, University of Cape Town, Cape Town, South Africa.
- Sustainable multi-target drugs for neglected tropical diseases caused by trypanosomatids: dream or reality? by Maria Laura BOLOGNESI, Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Bologna, Italy.
- Current pipeline of antimalarial therapies, by Benoît LALEU, Medicines for Malaria Venture (MMV), Department ICC, University of Geneva, Geneva, Switzerland.
- Highly sensitive bioluminescence imaging models for Chagas disease drug discovery, by John M. KELLY, London School of Hygiene and Tropical Medicine, London, UK.
- Antibiotic translocation and membrane barrier: New insights to combat bacterial resistance, by Jean-Marie PAGÈS, UMR-MD1, TMCD2, Aix-Marseille University, IRBA, Marseille, France.
- Multicomponent reactions with heterocycles: A source of novel scaffolds for antiparasitic and antiviral agents, by Rodolfo Lavilla, University of Barcelona, Spain.
- Structure guided design of Xanthomonas oryzae pv. oryzae topoisomerase I inhibitors, by Lakindu Samaranayake, University of Colombo, Sri Lanka.
- Design of potential antimalarial agents based on a homology model of Plasmodium falciparum glucose-6-phosphate dehydrogenase, by Caterina Pont, University of Barcelona, Spain.
- Structure-activity relationship of Arg10-teixobactin: A recently discovered antimicrobial peptide, by Fernando Albericio, University of KwaZulu-Natal, South Africa, and University of Barcelona, Spain.
- Diversity-oriented synthesis and chemical genetics of peptidomimetics to address lead discovery of anti-infective agents, by Andrea Trabocchi, University of Florence, Italy.
- The search for new antimicrobial agents, by site-selective peptide modification, by Alicia Boto, CSIC Institute of Natural Products and Agrobiology, Spain.
- Design and synthesis of cysteine protease inhibitors, by Florenci González Adelantado, University Jaume I, Spain.
- Lipid-oligonucleotide conjugates forming G-quadruplex (lipoquads) as potent inhibitors of HIV entry, by Ramon Eritja, IQAC-CSIC, Spain.
- Nitrosyl [2Fe-2S] ferredoxin mimetics as new nitric oxide donating antibacterial agents, by Nataliya Sanina, Russian Academy of Sciences, Russia.
- Cultivated and natural plant flora with antibacterial action collected from Palestine, by Hazem D. Sawalha, Arab American University, Palestine.
Conflicts of Interest
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Muñoz-Torrero, D.; Chibale, K. Introduction to the 1st Molecules Medicinal Chemistry Symposium (MMCS), Barcelona, 8 September 2017. Proceedings 2017, 1, 1098. https://doi.org/10.3390/proceedings1061098
Muñoz-Torrero D, Chibale K. Introduction to the 1st Molecules Medicinal Chemistry Symposium (MMCS), Barcelona, 8 September 2017. Proceedings. 2017; 1(6):1098. https://doi.org/10.3390/proceedings1061098
Chicago/Turabian StyleMuñoz-Torrero, Diego, and Kelly Chibale. 2017. "Introduction to the 1st Molecules Medicinal Chemistry Symposium (MMCS), Barcelona, 8 September 2017" Proceedings 1, no. 6: 1098. https://doi.org/10.3390/proceedings1061098